0 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP NI642485 2024-04-01 2025-03-31 NI642485 2025-03-31 NI642485 2024-03-31 NI642485 2023-04-01 2024-03-31 NI642485 2024-03-31 NI642485 2023-03-31 NI642485 bus:RegisteredOffice 2024-04-01 2025-03-31 NI642485 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 NI642485 bus:Director1 2024-04-01 2025-03-31 NI642485 core:WithinOneYear 2025-03-31 NI642485 core:WithinOneYear 2024-03-31 NI642485 core:ShareCapital 2025-03-31 NI642485 core:ShareCapital 2024-03-31 NI642485 core:RetainedEarningsAccumulatedLosses 2025-03-31 NI642485 core:RetainedEarningsAccumulatedLosses 2024-03-31 NI642485 bus:SmallEntities 2024-04-01 2025-03-31 NI642485 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 NI642485 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 NI642485 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 NI642485 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: NI642485
Gibsons Healthcare Ltd
Unaudited filleted financial statements
31 March 2025
Gibsons Healthcare Ltd
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Gibsons Healthcare Ltd
Directors and other information

| Director | Mr David Gibson
| Company number | NI642485
| Registered office | 225 Mountsandel Road
|  | Coleraine
|  | Derry
|  | BT52 1TB
| Accountants | PFS Accountants and Auditors Ltd
|  | 122 Main Street
|  | Dungiven
|  | Derry
|  | BT47 4LG

| Bankers | Danske Bank
|  | 46 Catherine Street
|  | Limavady
|  | Co. Derry
|  | BT49 9DB

Gibsons Healthcare Ltd
Report to the director on the preparation of the
unaudited statutory financial statements of Gibsons Healthcare Ltd
Year ended 31 March 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Gibsons Healthcare Ltd for the year ended 31 March 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the director of Gibsons Healthcare Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Gibsons Healthcare Ltd and state those matters that we have agreed to state to them, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Gibsons Healthcare Ltd and its director as a body for our work or for this report.
It is your duty to ensure that Gibsons Healthcare Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Gibsons Healthcare Ltd. You consider that Gibsons Healthcare Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Gibsons Healthcare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
PFS Accountants and Auditors Ltd
Chartered Certified Accountants
122 Main Street
Dungiven
Derry
BT47 4LG
20 February 2026
Gibsons Healthcare Ltd
Statement of financial position
31 March 2025

|  |  | 2025 |  |  |  | 2024 |  |
|  | Note | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |  |
Debtors |  | 4 | 100,133 |  |  |  | 100,133 |  |
Cash at bank and in hand |  |  | 42,518 |  |  |  | 43,001 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  | 142,651 |  |  |  | 143,134 |  |
Creditors: amounts falling due |  |  |  |  |  |  |  |  |
within one year |  | 5 | ( 784) |  |  |  | ( 763) |  |
|  |  | _______ |  |  |  | _______ |  |
Net current assets |  |  |  |  | 141,867 |  |  |  | 142,371
|  |  |  |  | _______ |  |  |  | _______
Total assets less current liabilities |  |  |  |  | 141,867 |  |  |  | 142,371
|  |  |  |  | _______ |  |  |  | _______
Net assets |  |  |  |  | 141,867 |  |  |  | 142,371
|  |  |  |  | _______ |  |  |  | _______
Capital and reserves |  |  |  |  |  |  |  |  |
Called up share capital |  |  |  |  | 133 |  |  |  | 133
Profit and loss account |  |  |  |  | 141,734 |  |  |  | 142,238
|  |  |  |  | _______ |  |  |  | _______
Shareholders funds |  |  |  |  | 141,867 |  |  |  | 142,371
|  |  |  |  | _______ |  |  |  | _______

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 20 February 2026 , and are signed on behalf of the board by:
Mr David Gibson
Director
Company registration number: NI642485
Gibsons Healthcare Ltd
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 225 Mountsandel Road, Coleraine, Derry, BT52 1TB.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors

|  |  | 2025 | 2024
|  |  | £ | £
| Other debtors |  | 100,133 | 100,133
|  |  | _______ | _______

5. Creditors: amounts falling due within one year

|  |  | 2025 | 2024
|  |  | £ | £
| Other creditors |  | 784 | 763
|  |  | _______ | _______